Technology
St. Jude Medical’s Promote RF CRT-D (cardiac resynchronization therapy defibrillator) and Current RF ICD (implantable cardioverter defibrillator) are radiofrequency (RF) wireless devices used to treat patients with heart failure and with potentially lethal heart arrhythmias.
September 03, 2008
News
September 3, 2008 – While a recent study into whether using unselected and selected bone-marrow derived cells can help with regeneration of heart tissue did not lead to significant improvement of LVEF and LV volumes in comparison to control group, there was a trend toward significant improvement of LVEF in patients with severely depressed baseline LVEF receiving either MNC or CD34 CXCR4 bone ma
September 03, 2008Feature | Dave Fornell
While the primary reason hospitals adopt new technology is to increase patient care and produce better outcomes, there are many other factors that also affect purchasing decisions.
September 03, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025Technology
Cook Medical recently launched the EVOLUTION-Shortie Mechanical Dilator Sheath Set, a tool for venous entry during ...
September 03, 2008Technology
Carestream Health’s CARESTREAM Virtual 3D Solution is a 3D software package designed to deliver advanced 3D processing ...
September 03, 2008Technology
Medtronic’s Concerto/Virtuoso line of implantable cardiac devices feature Medtronic’s proprietary Conexus Wireless Telemetry, developed using the Medical Implant Communications Service (MICS). Using the MICS band enables reliable communication between the implanted device and clinician programmers and patient home monitoring units.
September 03, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
September 1, 2008 - More than 22 million people worldwide suffer from heart failure, and most heart failure hospitalizations are due to excessive fluid accumulation in the chest cavity, and new data presented at the European Society of Cardiology Congress this week shows Medtronic’s devices equipped with OptiVol Fluid Status Monitoring Alerts may give advance warning of a patients’ worsening c
September 03, 2008Feature | Dave Fornell
As the new editor of Diagnostic and Invasive Cardiology (DAIC), I hope communication will not be one-sided with me presenting or reviewing new technology on the market. I would like to hear from the readers — the end users of these products — to find out your thoughts. I would also like to find out what you consider as important issues, or what technologies you would like to hear more about.
September 03, 2008
Feature | Dave Fornell
Tight inventory control in the cath and electrophysiology (EP) labs is critical to hospitals' bottom lines due to the expense of the items and their rapid expirations. A new technology showing big returns on investment is radio-frequency identification (RFID) tracking.
September 03, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
September 2, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used primarily in cardiology and radiology procedures, today said five new products are scheduled to be introduced over the next few months.
September 02, 2008News
September 2, 2008 – The European Society of Cardiology (ESC) released new guidelines for how doctors should handle an acute pulmonary embolism (PE), during its 2008 Congress in Munich, Germany today.
September 02, 2008News
September 3, 2008 - Edwards Lifesciences Corp. today said it received FDA approval for the Carpentier-Edwards PERIMOUNT ...
September 02, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
Edwards Lifesciences Corp. produces the Carpentier-Edwards The PERIMOUNT Magna mitral valve was launched in Europe in September 2005. It incorporates features of the Carpentier-Edwards PERIMOUNT mitral valve, which has demonstrated 16 years of durability, including the treatment of the bovine pericardial tissue leaflets with the Carpentier-Edwards ThermaFix process. September 2008
September 02, 2008News
September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty ...
September 02, 2008News
September 1, 2008 - Depression and heart disease are the two leading disorders with the strongest contributions to the ...
September 02, 2008